Bold Vision. Innovation at its best.
For almost 30 years, ProPhase has been relentlessly focused on enhancing wellness and improving health. Historically, we have been a diversified medical science and technology company that delivers breakthrough, clinically shown supplements and OTC manufacturing. In 2020, we pivoted to build out state of the art CLIA labs for COVID-19 diagnostic testing. In 2021, we acquired Nebula Genomics and formed ProPhase Precision Medicine. We are rapidly developing into a true biotech and genomics company that will leverage our CLIA laboratories for COVID-19 Testing, whole genome sequencing and a wide variety of diagnostic testing.